Finance

Lists
Q3 2026 earnings • released • EPS beat +3.01% • Revenue beat +9.04%
See results
CHRW:NASDAQ
CH Robinson Worldwide Inc
$124.61
-2.21%
(-2.82) 1D
$124.61
0.00% (0.00)
After hours
Closed: Oct 30, 3:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHRW...
Open
$127.47
High
$128.42
Low
$122.21
Mkt. cap
14.39B
Avg. vol.
2.09M
Volume
4.34M
Dividend
2.02%
Quarterly dividend
$0.63
Ex-dividend date
Sep 4, 2026
P/E ratio
22.38
52-wk high
$210.33
52-wk low
$122.21
EPS
$5.57
Beta
0.94
Shares outstanding
115.46M
No. of employees
11K
Open
$127.47
High
$128.42
Low
$122.21
Mkt. cap
14.39B
Avg. vol.
2.09M
Volume
4.34M
Dividend
2.02%
Quarterly dividend
$0.63
Ex-dividend date
Sep 4, 2026
P/E ratio
22.38
52-wk high
$210.33
52-wk low
$122.21
EPS
$5.57
Beta
0.94
Shares outstanding
115.46M
No. of employees
11K
News stories
From web sources and news partners
Profile
C.H. Robinson Worldwide, Inc. is an American transportation company that includes third-party logistics. The company offers freight transportation, transportation management, brokerage and warehousing. It offers truckload, less than truckload, air freight, intermodal, and ocean transportation. Wikipedia
About CH Robinson Worldwide Inc
CEODave Bozeman
Employees11.1K
Founded1905
HeadquartersEden Prairie, Minnesota, United States
SectorAir cargo
Analyst ratings
Based on 18 analysts giving stock ratings to CHRW in the past 3 months
Buy
Buy
13
Hold
5
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for CHRW in the last 3 months.
Highest
Current $124.61
$217.00 (+74.14%)
Average
$181.11 (+45.34%)
Lowest
$145.00 (+16.36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sergey Glinyanov
Freedom Capital Markets
Buy
Maintained
$185.00
+48.5%
10/30/2026
Daniel Moore CFA
Robert W. Baird
Buy
Maintained
$175.00
+40.4%
10/30/2026
Lucas Servera
Truist Financial
Buy
Maintained
$180.00
+44.5%
10/29/2026
Brian Ossenbeck
J.P. Morgan
Buy
Maintained
$174.00
+39.6%
10/29/2026
Jason Seidl
TD Cowen
Hold
Reiterated
$145.00
+16.4%
10/29/2026
Thomas Wadewitz
UBS
Buy
Reiterated
$204.00
+63.7%
10/29/2026
Fadi Chamoun
BMO Capital
Hold
Reiterated
$160.00
+28.4%
10/28/2026
Bascome Majors
Stephens
Buy
Maintained
$190.00
+52.5%
10/29/2026
Christian Wetherbee
Wells Fargo
Buy
Reiterated
$200.00
+60.5%
10/29/2026
J. Bruce Chan
Stifel Nicolaus
Buy
Maintained
$198.00
+58.9%
10/29/2026
Ariel Rosa
Citi
Buy
Maintained
$183.00
+46.9%
10/30/2026
Brandon Oglenski
Barclays
Buy
Maintained
$210.00
+68.5%
10/29/2026
Ken Hoexter
Bank of America Securities
Buy
Reiterated
$185.00
+48.5%
10/29/2026
David Vernon
Bernstein
Hold
Maintained
$151.00
+21.2%
10/23/2026
David Hicks CFA
Raymond James
Buy
Maintained
$170.00
+36.4%
10/15/2026
Richa Harnain
Deutsche Bank
Hold
Downgraded
$153.00
+22.8%
10/12/2026
Jonathan Chappell
Evercore ISI
Buy
Maintained
$217.00
+74.1%
10/06/2026
Alex Irving
Bernstein
Hold
Maintained
$151.00
+21.2%
09/25/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$215.00
+72.5%
08/07/2026
Jordan Alliger
Goldman Sachs
Hold
Maintained
$180.00
+44.5%
08/04/2026
Scott Group
Wolfe Research
Buy
Maintained
$196.00
+57.3%
07/29/2026
Ravi Shanker
Morgan Stanley
Sell
Maintained
$91.00
-27%
07/30/2026
Jeff Kauffman
Citizens JMP
Buy
Initiated
$235.00
+88.6%
07/15/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
$235.00
+88.6%
07/15/2026
Harrison Bauer
Susquehanna
Buy
Maintained
$226.00
+81.4%
07/14/2026
Unknown Analyst
Stephens
Buy
Initiated
$225.00
+80.6%
07/08/2026
Stephanie Moore
Jefferies
Buy
Upgraded
$200.00
+60.5%
05/20/2026
Christopher Kuhn
Benchmark Co.
Buy
Maintained
$205.00
+64.5%
01/29/2026
Last report
Oct 28, 2026
Fiscal period
Q3 2026
$1.80 / $1.75
+3.01%beat
Revenue / Est. (USD)
5.36B / 4.91B
+9.04%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.91B
4.01B
4.93B
5.36B
Cost of goods sold
3.58B
3.69B
4.53B
4.91B
Cost of revenue
3.58B
3.69B
4.53B
4.91B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
136.81M
129.65M
144.20M
176.33M
Operating expense
136.81M
129.65M
144.20M
176.33M
Total operating expenses
3.71B
3.82B
4.67B
5.09B
Operating income
198.40M
196.89M
263.31M
271.81M
Other non operating income
-
3.29M
422.00K
-
EBT including unusual items
166.53M
166.67M
237.86M
250.09M
EBT excluding unusual items
183.58M
187.88M
245.43M
250.09M
Income tax expense
30.21M
19.44M
51.08M
51.62M
Effective tax rate
18.14%
11.66%
21.47%
20.64%
Other operating expenses
-
-
-
-
Net income
136.32M
147.23M
186.79M
198.47M
Net profit margin
3.48%
3.67%
3.79%
3.70%
Earnings per share
1.23
1.35
1.61
1.80
Interest and investment income
1.78M
-
-
-
Interest expense
-13.70M
-14.00M
-16.90M
-21.72M
Net interest expenses
-11.92M
-14.00M
-16.90M
-21.72M
Depreciation and amortization charges
-
-
-
-
EBITDA
208.61M
207.88M
273.84M
321.48M
Gain or loss from assets sale
-287.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps